Airway Medix réussit son premier audit de surveillance et conserve sa certification ISO 13485
Airway Medix a réussi son premier audit de surveillance ISO 13485 sans aucune non-conformité et conserve le certificat délivré par CeCert. Le système certifié couvre la conception, la fabrication et la vente des dispositifs médicaux de l’entreprise et accompagne ses activités dans l’UE, aux États-Unis et sur d’autres marchés.
Texte intégral en anglais (original)
Warsaw, July 20, 2026: Airway Medix S.A., a MedTech company listed on the Warsaw Stock Exchange focused on clinical airway management solutions, announced that it has successfully passed its first surveillance audit of its Quality Management System under the PN-EN ISO 13485 standard, with a positive result and no nonconformities identified. As a result, the Company maintains the certificate issued by CeCert Sp. z o.o., an accredited certification body.
The certification covers Airway Medix's product design and development, manufacturing, and sales processes for its medical device portfolio. Maintaining ISO 13485 certification is a key requirement supporting the Company's ability to sell its medical devices across European, American, and other international markets.
ISO 13485, "Medical devices, Quality management systems, Requirements for regulatory purposes", is recognized internationally as the benchmark framework for meeting the comprehensive quality management requirements applicable to medical device manufacturers.
The maintained certification comes as Airway Medix continues to build on the transformation it completed: moving its R&D, production, and regulatory functions to Europe and shifting from a research-focused organization into a commercially driven business, with its first product reaching the market in early 2026. The Company continues to sell its products and is working to further internationalize its management structure as it grows its presence across European markets, the Gulf region, and the United States.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative disposable devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Les communiqués de presse sont publiés tels qu’émis par Airway Medix S.A. Les informations sur les produits s’appuient sur la notice d’utilisation.
